Paul Cardozo Gil
Research Subjects
Paul Cardozo Gil has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Jhossmar Cristians Auza-Santivañez
Hospital del Gran Chaco “Fray Quebracho” de III nivel. Instituto Académico Científico Quispe-Cornejo. Tarija, Bolivia
8 shared publications - Freddy Ednildon Bautista-Vanegas
Kliniken Beelitz GmbH Neurologische Rehabilitationsklinik: Beelitz Heilstätten, Brandenburg, DE. Alemania
5 shared publications - Jorge Márquez-Molina
Hospital del Norte. Cochabamba, Bolivia
4 shared publications - Mildred Ericka Kubatz La Madrid
Hospital de Tercer Nivel Dr. Hernán Messuti Ribera. Jefe del Servicio de Imagenología. Pando, Bolivia
4 shared publications - Blas Apaza-Huanca
Ministerio de Salud y Deportes. Instituto Académico Científico Quispe-Cornejo. La Paz, Bolivia
3 shared publications - Carlos Alberto Paz-Román
Hospital de Niños Dr. Mario Ortíz Suárez, Santa cruz Bolivia
3 shared publications
Latest Publications
- 27 July 2026
- Published by South American Publishing
Introducción a la Medicina Basada en la Evidencia
Introducción. La Medicina Basada en la Evidencia (MBE) es un modelo de práctica clínica que integra la mejor evidencia científica disponible, la experiencia clínica del profesional y los valores y preferencias del pacien
- 27 July 2026
- Published by South American Publishing
Introducción a la Medicina Basada en la Evidencia
Introducción. La Medicina Basada en la Evidencia (MBE) es un modelo de práctica clínica que integra la mejor evidencia científica disponible, la experiencia clínica del profesional y los valores y preferencias del pacien
- Open Access
- 27 July 2026
- Published by South American Publishing
Critical reading of scientific articles on health: A practical guide (Spanish Edition)
The rapid expansion of biomedical literature has increased the need for healthcare professionals to critically evaluate scientific evidence before incorporating it into clinical practice. This book presents a comprehensi
- 27 July 2026
- Published by South American Publishing
Open AccessCritical reading of scientific articles on health: A practical guide (Spanish Edition)
The rapid expansion of biomedical literature has increased the need for healthcare professionals to critically evaluate scientific evidence before incorporating it into clinical practice. This book presents a comprehensi
- Open Access
- 24 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7) , e113285
Severe Pulmonary Differentiation Syndrome Despite Corticosteroid Prophylaxis in Acute Promyelocytic Leukemia: Clinical Improvement With Pulse Methylprednisolone Therapy and High-Flow Nasal Cannula
Differentiation syndrome (DS) is a potentially life-threatening complication of differentiation therapy in acute promyelocytic leukemia (APL), particularly with all-trans retinoic acid (ATRA) and arsenic trioxide. We report the case of a 37-year-old woman with newly diagnosed APL who developed severe pulmonary DS 48 hours after ATRA initiation despite dexamethasone prophylaxis. She developed progressive hyperleukocytosis, fluid retention, severe hypoxemia, and diffuse bilateral pulmonary infiltrates, requiring high-flow nasal cannula (HFNC) support with an FiO₂ of up to 80% and a flow rate of 60 L/min, combined with awake prone positioning. The initial PaO₂/FiO₂ ratio was 150, and the respiratory rate-oxygenation (ROX) index was 4, indicating a clinical profile associated with a higher risk of intubation. In the absence of bacterial growth from respiratory samples or a cardiogenic cause, DS was considered the predominant mechanism of respiratory deterioration. After 48 hours of HFNC support, the ROX index increased to 8; however, persistent pulmonary involvement prompted escalation to pulse methylprednisolone therapy at 1 g/day for three days. The patient showed clinical, oxygenation, and radiologic improvement, with an increase in the PaO₂/FiO₂ ratio from 150 to 350, and invasive mechanical ventilation was avoided. This case highlights the importance of early recognition of severe pulmonary DS in APL and suggests that individualized corticosteroid intensification combined with advanced noninvasive respiratory support may be useful in selected high-risk patients.
- 24 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7) , e113285
Open AccessSevere Pulmonary Differentiation Syndrome Despite Corticosteroid Prophylaxis in Acute Promyelocytic Leukemia: Clinical Improvement With Pulse Methylprednisolone Therapy and High-Flow Nasal Cannula
Differentiation syndrome (DS) is a potentially life-threatening complication of differentiation therapy in acute promyelocytic leukemia (APL), particularly with all-trans retinoic acid (ATRA) and arsenic trioxide. We report the case of a 37-year-old woman with newly diagnosed APL who developed severe pulmonary DS 48 hours after ATRA initiation despite dexamethasone prophylaxis. She developed progressive hyperleukocytosis, fluid retention, severe hypoxemia, and diffuse bilateral pulmonary infiltrates, requiring high-flow nasal cannula (HFNC) support with an FiO₂ of up to 80% and a flow rate of 60 L/min, combined with awake prone positioning. The initial PaO₂/FiO₂ ratio was 150, and the respiratory rate-oxygenation (ROX) index was 4, indicating a clinical profile associated with a higher risk of intubation. In the absence of bacterial growth from respiratory samples or a cardiogenic cause, DS was considered the predominant mechanism of respiratory deterioration. After 48 hours of HFNC support, the ROX index increased to 8; however, persistent pulmonary involvement prompted escalation to pulse methylprednisolone therapy at 1 g/day for three days. The patient showed clinical, oxygenation, and radiologic improvement, with an increase in the PaO₂/FiO₂ ratio from 150 to 350, and invasive mechanical ventilation was avoided. This case highlights the importance of early recognition of severe pulmonary DS in APL and suggests that individualized corticosteroid intensification combined with advanced noninvasive respiratory support may be useful in selected high-risk patients.
- Open Access
- 24 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (6) , e72786
Beyond Vasospasm: Dual Milrinone and Balloon Angioplasty in Refractory Delayed Cerebral Ischemia Post‐Subarachnoid Hemorrhage
Cerebral vasospasm is a major complication of aneurysmal subarachnoid hemorrhage and a key contributor to delayed cerebral ischemia, which remains a leading cause of morbidity despite standard therapy with nimodipine and induced hypertension. Up to 30% of patients develop refractory delayed cerebral ischemia, highlighting the need for alternative therapeutic strategies. Milrinone has emerged as a promising option due to its combined vasodilatory and inotropic properties. We report the case of a 42‐year‐old man who developed progressive neurological deterioration following aneurysmal subarachnoid hemorrhage secondary to rupture of an anterior cerebral artery aneurysm. Despite definitive microsurgical clipping and optimal standard management, the patient developed refractory delayed cerebral ischemia with severe vasospasm. A stepwise, physiology‐guided treatment strategy was implemented, including high‐dose intravenous milrinone infusion, intra‐arterial milrinone administration, and rescue balloon angioplasty. This approach resulted in significant angiographic improvement, progressive neurological recovery, and successful ventilatory weaning. This case highlights the value of a multimodal, escalation‐based strategy for the management of refractory delayed cerebral ischemia, supporting the use of milrinone as a potential first‐line rescue therapy and reserving balloon angioplasty for non‐responders. It reinforces the concept of delayed cerebral ischemia as a multifactorial process and underscores the critical role of intensive neuromonitoring in enabling safe and effective therapeutic escalation.
- 24 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (6) , e72786
Open AccessBeyond Vasospasm: Dual Milrinone and Balloon Angioplasty in Refractory Delayed Cerebral Ischemia Post‐Subarachnoid Hemorrhage
Cerebral vasospasm is a major complication of aneurysmal subarachnoid hemorrhage and a key contributor to delayed cerebral ischemia, which remains a leading cause of morbidity despite standard therapy with nimodipine and induced hypertension. Up to 30% of patients develop refractory delayed cerebral ischemia, highlighting the need for alternative therapeutic strategies. Milrinone has emerged as a promising option due to its combined vasodilatory and inotropic properties. We report the case of a 42‐year‐old man who developed progressive neurological deterioration following aneurysmal subarachnoid hemorrhage secondary to rupture of an anterior cerebral artery aneurysm. Despite definitive microsurgical clipping and optimal standard management, the patient developed refractory delayed cerebral ischemia with severe vasospasm. A stepwise, physiology‐guided treatment strategy was implemented, including high‐dose intravenous milrinone infusion, intra‐arterial milrinone administration, and rescue balloon angioplasty. This approach resulted in significant angiographic improvement, progressive neurological recovery, and successful ventilatory weaning. This case highlights the value of a multimodal, escalation‐based strategy for the management of refractory delayed cerebral ischemia, supporting the use of milrinone as a potential first‐line rescue therapy and reserving balloon angioplasty for non‐responders. It reinforces the concept of delayed cerebral ischemia as a multifactorial process and underscores the critical role of intensive neuromonitoring in enabling safe and effective therapeutic escalation.
- Open Access
- 14 April 2025
- Published by South American Publishing in Salud Integral y Comunitaria
- Vol. 3, 120
Immune thrombocytopenia a key piece of the puzzle for the diagnosis of atypical systemic lupus erythematosus in critically ill patients. Case report
Introduction: immune thrombocytopenia (ITP) is an autoimmune disorder characterized by autoantibody-mediated destruction of platelets, resulting in low platelet count and increased risk of bleeding, and may be an initial manifestation of systemic lupus erythematosus (SLE), especially in patients with findings suggestive of autoimmunity.Clinical Case: a 52-year-old male presented with fever, hematuria, generalized petechiae (including mucous membranes), myalgia, mucosal bleeding, oliguria progressive to anuria, and severe arterial hypertension. Initial studies revealed severe anemia, severe thrombocytopenia, and acute kidney injury, which led to his admission to the Intensive Care Unit (ICU). Complementary studies showed positive ANA, low complement (C3, C4), and positive anti-Ro, while anti-dsDNA antibodies, ANCA, and markers of antiphospholipid syndrome were negative. Imaging revealed pulmonary edema with mild alveolar hemorrhage and renal ultrasound findings consistent with active lupus nephritis. These findings raised the possibility that severe thrombocytopenia was a prelude to SLE. After initial treatment refractory, the patient was escalated to rituximab, with a favorable response without complications, which allowed discharge from the ICU.Conclusions: this case highlights the importance of considering SLE in patients with refractory thrombocytopenia without apparent cause, even in men, and underlines the need for a multidisciplinary approach for timely diagnosis and treatment, thus preventing serious complications.
- 14 April 2025
- Published by South American Publishing in Salud Integral y Comunitaria
- Vol. 3, 120
Open AccessImmune thrombocytopenia a key piece of the puzzle for the diagnosis of atypical systemic lupus erythematosus in critically ill patients. Case report
Introduction: immune thrombocytopenia (ITP) is an autoimmune disorder characterized by autoantibody-mediated destruction of platelets, resulting in low platelet count and increased risk of bleeding, and may be an initial manifestation of systemic lupus erythematosus (SLE), especially in patients with findings suggestive of autoimmunity.Clinical Case: a 52-year-old male presented with fever, hematuria, generalized petechiae (including mucous membranes), myalgia, mucosal bleeding, oliguria progressive to anuria, and severe arterial hypertension. Initial studies revealed severe anemia, severe thrombocytopenia, and acute kidney injury, which led to his admission to the Intensive Care Unit (ICU). Complementary studies showed positive ANA, low complement (C3, C4), and positive anti-Ro, while anti-dsDNA antibodies, ANCA, and markers of antiphospholipid syndrome were negative. Imaging revealed pulmonary edema with mild alveolar hemorrhage and renal ultrasound findings consistent with active lupus nephritis. These findings raised the possibility that severe thrombocytopenia was a prelude to SLE. After initial treatment refractory, the patient was escalated to rituximab, with a favorable response without complications, which allowed discharge from the ICU.Conclusions: this case highlights the importance of considering SLE in patients with refractory thrombocytopenia without apparent cause, even in men, and underlines the need for a multidisciplinary approach for timely diagnosis and treatment, thus preventing serious complications.
- Open Access
- 9 February 2025
- Published by South American Publishing in SAP Multidisciplinary Open
- Vol. 3
Current perspectives in the diagnosis and management of bacterial meningitis. Literature review and update
Introduction: Bacterial meningitis is a serious and potentially fatal disease that has represented a significant challenge to medicine since its identification in the 19th century. Despite advances in antimicrobial treatment, it remains a major cause of morbidity and mortality worldwide. This review aims to update current perspectives on the diagnosis and management of bacterial meningitis, focusing on its pathogenesis, clinical manifestations, diagnostic methods, and therapeutic strategies. Methods: A search for information was carried out in the period August-December 2024 in the SciELO, LILACS, Scopus, PubMed-MedLine databases, the Google Scholar search engine, as well as in the ClinicalKeys services. For the recovery of information, an advanced search strategy was used and the terms “meningitis or bacterial meningitis” were used, as well as their translations into the English language. To combine the terms, Boolean operators were used, with search formulas according to the syntax requested by each database. Furthermore, in order to achieve a review based on the best possible evidence, only studies of the type case series, original articles or systematic reviews were selected. Results and discussion: Bacterial meningitis develops when pathogens overcome the host's defense mechanisms, colonizing mucous membranes, invading the bloodstream and penetrating the subarachnoid space. The main pathogens include Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae. The most common clinical manifestations are fever, headache, stiff neck and altered mental status. Diagnosis is based on analysis of cerebrospinal fluid (CSF), which shows pleocytosis, increased protein and decreased glucose. Empirical treatment includes antibiotics such as cefotaxime, ceftriaxone and vancomycin, together with dexamethasone as adjuvant therapy to reduce inflammation. Conclusions: Bacterial meningitis is a serious infection of the central nervous system, a medical emergency whose mortality and sequelae can be reduced with timely diagnosis and treatment. The key is to start treatment immediately and without delay. Prevention is the cornerstone of its control. Only through multidisciplinary management, which could include an expert infectious disease specialist, an intensive care physician, a specialized nurse and adequate laboratory equipment, can the impact of this devastating disease be mitigated.
- 9 February 2025
- Published by South American Publishing in SAP Multidisciplinary Open
- Vol. 3
Open AccessCurrent perspectives in the diagnosis and management of bacterial meningitis. Literature review and update
Introduction: Bacterial meningitis is a serious and potentially fatal disease that has represented a significant challenge to medicine since its identification in the 19th century. Despite advances in antimicrobial treatment, it remains a major cause of morbidity and mortality worldwide. This review aims to update current perspectives on the diagnosis and management of bacterial meningitis, focusing on its pathogenesis, clinical manifestations, diagnostic methods, and therapeutic strategies. Methods: A search for information was carried out in the period August-December 2024 in the SciELO, LILACS, Scopus, PubMed-MedLine databases, the Google Scholar search engine, as well as in the ClinicalKeys services. For the recovery of information, an advanced search strategy was used and the terms “meningitis or bacterial meningitis” were used, as well as their translations into the English language. To combine the terms, Boolean operators were used, with search formulas according to the syntax requested by each database. Furthermore, in order to achieve a review based on the best possible evidence, only studies of the type case series, original articles or systematic reviews were selected. Results and discussion: Bacterial meningitis develops when pathogens overcome the host's defense mechanisms, colonizing mucous membranes, invading the bloodstream and penetrating the subarachnoid space. The main pathogens include Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae. The most common clinical manifestations are fever, headache, stiff neck and altered mental status. Diagnosis is based on analysis of cerebrospinal fluid (CSF), which shows pleocytosis, increased protein and decreased glucose. Empirical treatment includes antibiotics such as cefotaxime, ceftriaxone and vancomycin, together with dexamethasone as adjuvant therapy to reduce inflammation. Conclusions: Bacterial meningitis is a serious infection of the central nervous system, a medical emergency whose mortality and sequelae can be reduced with timely diagnosis and treatment. The key is to start treatment immediately and without delay. Prevention is the cornerstone of its control. Only through multidisciplinary management, which could include an expert infectious disease specialist, an intensive care physician, a specialized nurse and adequate laboratory equipment, can the impact of this devastating disease be mitigated.
- Open Access
- 9 February 2025
- Published by South American Publishing in SAP Multidisciplinary Open
- Vol. 3, 191
Current perspectives in the diagnosis and management of bacterial meningitis. Literature review and update
Introduction: Bacterial meningitis is a serious and potentially fatal disease that has represented a significant challenge to medicine since its identification in the 19th century. Despite advances in antimicrobial treatment, it remains a major cause of morbidity and mortality worldwide. This review aims to update current perspectives on the diagnosis and management of bacterial meningitis, focusing on its pathogenesis, clinical manifestations, diagnostic methods, and therapeutic strategies. Methods: A search for information was carried out in the period August-December 2024 in the SciELO, LILACS, Scopus, PubMed-MedLine databases, the Google Scholar search engine, as well as in the ClinicalKeys services. For the recovery of information, an advanced search strategy was used and the terms “meningitis or bacterial meningitis” were used, as well as their translations into the English language. To combine the terms, Boolean operators were used, with search formulas according to the syntax requested by each database. Furthermore, in order to achieve a review based on the best possible evidence, only studies of the type case series, original articles or systematic reviews were selected. Results and discussion: Bacterial meningitis develops when pathogens overcome the host's defense mechanisms, colonizing mucous membranes, invading the bloodstream and penetrating the subarachnoid space. The main pathogens include Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae. The most common clinical manifestations are fever, headache, stiff neck and altered mental status. Diagnosis is based on analysis of cerebrospinal fluid (CSF), which shows pleocytosis, increased protein and decreased glucose. Empirical treatment includes antibiotics such as cefotaxime, ceftriaxone and vancomycin, together with dexamethasone as adjuvant therapy to reduce inflammation. Conclusions: Bacterial meningitis is a serious infection of the central nervous system, a medical emergency whose mortality and sequelae can be reduced with timely diagnosis and treatment. The key is to start treatment immediately and without delay. Prevention is the cornerstone of its control. Only through multidisciplinary management, which could include an expert infectious disease specialist, an intensive care physician, a specialized nurse and adequate laboratory equipment, can the impact of this devastating disease be mitigated.
- 9 February 2025
- Published by South American Publishing in SAP Multidisciplinary Open
- Vol. 3, 191
Open AccessCurrent perspectives in the diagnosis and management of bacterial meningitis. Literature review and update
Introduction: Bacterial meningitis is a serious and potentially fatal disease that has represented a significant challenge to medicine since its identification in the 19th century. Despite advances in antimicrobial treatment, it remains a major cause of morbidity and mortality worldwide. This review aims to update current perspectives on the diagnosis and management of bacterial meningitis, focusing on its pathogenesis, clinical manifestations, diagnostic methods, and therapeutic strategies. Methods: A search for information was carried out in the period August-December 2024 in the SciELO, LILACS, Scopus, PubMed-MedLine databases, the Google Scholar search engine, as well as in the ClinicalKeys services. For the recovery of information, an advanced search strategy was used and the terms “meningitis or bacterial meningitis” were used, as well as their translations into the English language. To combine the terms, Boolean operators were used, with search formulas according to the syntax requested by each database. Furthermore, in order to achieve a review based on the best possible evidence, only studies of the type case series, original articles or systematic reviews were selected. Results and discussion: Bacterial meningitis develops when pathogens overcome the host's defense mechanisms, colonizing mucous membranes, invading the bloodstream and penetrating the subarachnoid space. The main pathogens include Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae. The most common clinical manifestations are fever, headache, stiff neck and altered mental status. Diagnosis is based on analysis of cerebrospinal fluid (CSF), which shows pleocytosis, increased protein and decreased glucose. Empirical treatment includes antibiotics such as cefotaxime, ceftriaxone and vancomycin, together with dexamethasone as adjuvant therapy to reduce inflammation. Conclusions: Bacterial meningitis is a serious infection of the central nervous system, a medical emergency whose mortality and sequelae can be reduced with timely diagnosis and treatment. The key is to start treatment immediately and without delay. Prevention is the cornerstone of its control. Only through multidisciplinary management, which could include an expert infectious disease specialist, an intensive care physician, a specialized nurse and adequate laboratory equipment, can the impact of this devastating disease be mitigated.
- Open Access
- 23 January 2025
- Published by South American Publishing in Salud Integral y Comunitaria
- Vol. 3, 120
Immune thrombocytopenia a key piece of the puzzle for the diagnosis of atypical systemic lupus erythematosus in critically ill patients. Case report
Introduction: immune thrombocytopenia (ITP) is an autoimmune disorder characterized by autoantibody-mediated destruction of platelets, resulting in low platelet count and increased risk of bleeding, and may be an initial manifestation of systemic lupus erythematosus (SLE), especially in patients with findings suggestive of autoimmunity.Clinical Case: a 52-year-old male presented with fever, hematuria, generalized petechiae (including mucous membranes), myalgia, mucosal bleeding, oliguria progressive to anuria, and severe arterial hypertension. Initial studies revealed severe anemia, severe thrombocytopenia, and acute kidney injury, which led to his admission to the Intensive Care Unit (ICU). Complementary studies showed positive ANA, low complement (C3, C4), and positive anti-Ro, while anti-dsDNA antibodies, ANCA, and markers of antiphospholipid syndrome were negative. Imaging revealed pulmonary edema with mild alveolar hemorrhage and renal ultrasound findings consistent with active lupus nephritis. These findings raised the possibility that severe thrombocytopenia was a prelude to SLE. After initial treatment refractory, the patient was escalated to rituximab, with a favorable response without complications, which allowed discharge from the ICU.Conclusions: this case highlights the importance of considering SLE in patients with refractory thrombocytopenia without apparent cause, even in men, and underlines the need for a multidisciplinary approach for timely diagnosis and treatment, thus preventing serious complications.
- 23 January 2025
- Published by South American Publishing in Salud Integral y Comunitaria
- Vol. 3, 120
Open AccessImmune thrombocytopenia a key piece of the puzzle for the diagnosis of atypical systemic lupus erythematosus in critically ill patients. Case report
Introduction: immune thrombocytopenia (ITP) is an autoimmune disorder characterized by autoantibody-mediated destruction of platelets, resulting in low platelet count and increased risk of bleeding, and may be an initial manifestation of systemic lupus erythematosus (SLE), especially in patients with findings suggestive of autoimmunity.Clinical Case: a 52-year-old male presented with fever, hematuria, generalized petechiae (including mucous membranes), myalgia, mucosal bleeding, oliguria progressive to anuria, and severe arterial hypertension. Initial studies revealed severe anemia, severe thrombocytopenia, and acute kidney injury, which led to his admission to the Intensive Care Unit (ICU). Complementary studies showed positive ANA, low complement (C3, C4), and positive anti-Ro, while anti-dsDNA antibodies, ANCA, and markers of antiphospholipid syndrome were negative. Imaging revealed pulmonary edema with mild alveolar hemorrhage and renal ultrasound findings consistent with active lupus nephritis. These findings raised the possibility that severe thrombocytopenia was a prelude to SLE. After initial treatment refractory, the patient was escalated to rituximab, with a favorable response without complications, which allowed discharge from the ICU.Conclusions: this case highlights the importance of considering SLE in patients with refractory thrombocytopenia without apparent cause, even in men, and underlines the need for a multidisciplinary approach for timely diagnosis and treatment, thus preventing serious complications.
- Open Access
- 15 January 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 3, .252
Mountain sickness: physiological challenges, diagnosis and treatment
INTRODUCTION. The first descriptions of altitude sickness were made in (1540-1600). Nowadays, different cities in the world are at high altitude, for example Qinghai-Tibetan Plateau in China occupies an area of almost 2.5 million inhabitants km2, with an average elevation of over 4,500 m. Altitude sickness should be a major concern for anyone who normally resides at sea level. METHOD. A search for information was carried out in the period August-December 2024 in the SciELO, LILACS, Scopus, PubMed-MedLine databases, the Google Scholar search engine, as well as in the ClinicalKeys services. RESULTS AND DISCUSSION. The partial pressure of arterial oxygen (PaO2 ) decreases with altitude, which produces progressive tissue hypoxia. The normal compensatory response to hypobaric hypoxia is called acclimatization. Its main characteristic is increased ventilation. The ability to acclimatize varies widely among individuals and depends on many factors, including the degree of hypoxic stress (rate of ascent, altitude reached), the intrinsic ability of the individual to compensate for the decrease in PaO2, and extrinsic factors. Progressive ascent produces greater hypoxic stress, requiring greater degrees of physiological and behavioral adaptations to preserve function. The more rapid the ascent and the higher the altitude, the greater the stress. Below 1500 m, symptoms of high altitude illness are generally not manifest. From approximately 1500 to 2500 m, symptoms are generally mild, if experienced at all. From approximately 2500 m, mild to moderate symptoms become quite common among unacclimatized visitors after a rapid ascent. As a general rule, people who normally reside below 1500 m should avoid an abrupt ascent to altitudes above 2800 m for sleeping. Sedative-hypnotics should be avoided during acclimatization. Abstinence from alcohol is safest
- 15 January 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 3, .252
Open AccessMountain sickness: physiological challenges, diagnosis and treatment
INTRODUCTION. The first descriptions of altitude sickness were made in (1540-1600). Nowadays, different cities in the world are at high altitude, for example Qinghai-Tibetan Plateau in China occupies an area of almost 2.5 million inhabitants km2, with an average elevation of over 4,500 m. Altitude sickness should be a major concern for anyone who normally resides at sea level. METHOD. A search for information was carried out in the period August-December 2024 in the SciELO, LILACS, Scopus, PubMed-MedLine databases, the Google Scholar search engine, as well as in the ClinicalKeys services. RESULTS AND DISCUSSION. The partial pressure of arterial oxygen (PaO2 ) decreases with altitude, which produces progressive tissue hypoxia. The normal compensatory response to hypobaric hypoxia is called acclimatization. Its main characteristic is increased ventilation. The ability to acclimatize varies widely among individuals and depends on many factors, including the degree of hypoxic stress (rate of ascent, altitude reached), the intrinsic ability of the individual to compensate for the decrease in PaO2, and extrinsic factors. Progressive ascent produces greater hypoxic stress, requiring greater degrees of physiological and behavioral adaptations to preserve function. The more rapid the ascent and the higher the altitude, the greater the stress. Below 1500 m, symptoms of high altitude illness are generally not manifest. From approximately 1500 to 2500 m, symptoms are generally mild, if experienced at all. From approximately 2500 m, mild to moderate symptoms become quite common among unacclimatized visitors after a rapid ascent. As a general rule, people who normally reside below 1500 m should avoid an abrupt ascent to altitudes above 2800 m for sleeping. Sedative-hypnotics should be avoided during acclimatization. Abstinence from alcohol is safest
- Open Access
- 1 January 2025
- Published by South American Publishing in Rehabilitation and Sports Medicine
- Vol. 5, 25
Neurological complications in patients with Human Immunodeficiency Virus infection at the Japanese Hospital in Santa Cruz, Bolivia
Introduction: Neurological involvement is common among patients with Human Immunodeficiency Virus (HIV) infection. Between 40 and 60% will develop symptomatic neurological complications with high morbidity and mortality at some point. Objective: To analyze the clinical-epidemiological characteristics of patients with HIV infection who develop neurological complications at the Japanese Hospital of Santa Cruz de la Sierra in the period between March 2019 and February 2022.Methods: Observational, descriptive, prospective, cross-sectional study. Universe and Sample: Patients admitted through the Emergency Service of the Japanese Hospital with a confirmed diagnosis of Human Immunodeficiency Virus Disease during the period between March 2019 and February 2022Results and discussion: A total of 42 patients were evaluated, the majority of whom were men and had a younger average age. For both sexes, the majority of patients reported having a source of employment. Regarding sexual orientation, almost all women reported being heterosexual, while men were more variable, with the majority being bisexual. Three clinical syndromes were identified at admission. The frequency of focal syndrome was dominant in women, but was not significantly different from the others. In men, meningeal syndrome and focal syndrome were the dominant ones, significantly exceeding non-focal syndrome. Ten neurological complications were identified, cerebral toxoplasmosis was the most frequent, followed by cerebral cryptococcosis and meningeal tuberculosis. Considering all patients in general, their typical hospital stay was 11 days with a range between 2 and 56 days. Of the 42 patients evaluated, it was only possible to measure the CD4 status for 27.Conclusions: The young male population with employment in the city of Santa Cruz with aberrant sexual behavior was the most affected. Focal syndrome was the most frequent form of presentation, in the form of cerebral toxoplasmosis. Severely low levels of immunosuppression were found in the study population. Hospital stay is variable and is longer in cases of focal syndrome and meningeal syndrome. We consider it important to continue the present study, which will allow us to increase the sample size.
- 1 January 2025
- Published by South American Publishing in Rehabilitation and Sports Medicine
- Vol. 5, 25
Open AccessNeurological complications in patients with Human Immunodeficiency Virus infection at the Japanese Hospital in Santa Cruz, Bolivia
Introduction: Neurological involvement is common among patients with Human Immunodeficiency Virus (HIV) infection. Between 40 and 60% will develop symptomatic neurological complications with high morbidity and mortality at some point. Objective: To analyze the clinical-epidemiological characteristics of patients with HIV infection who develop neurological complications at the Japanese Hospital of Santa Cruz de la Sierra in the period between March 2019 and February 2022.Methods: Observational, descriptive, prospective, cross-sectional study. Universe and Sample: Patients admitted through the Emergency Service of the Japanese Hospital with a confirmed diagnosis of Human Immunodeficiency Virus Disease during the period between March 2019 and February 2022Results and discussion: A total of 42 patients were evaluated, the majority of whom were men and had a younger average age. For both sexes, the majority of patients reported having a source of employment. Regarding sexual orientation, almost all women reported being heterosexual, while men were more variable, with the majority being bisexual. Three clinical syndromes were identified at admission. The frequency of focal syndrome was dominant in women, but was not significantly different from the others. In men, meningeal syndrome and focal syndrome were the dominant ones, significantly exceeding non-focal syndrome. Ten neurological complications were identified, cerebral toxoplasmosis was the most frequent, followed by cerebral cryptococcosis and meningeal tuberculosis. Considering all patients in general, their typical hospital stay was 11 days with a range between 2 and 56 days. Of the 42 patients evaluated, it was only possible to measure the CD4 status for 27.Conclusions: The young male population with employment in the city of Santa Cruz with aberrant sexual behavior was the most affected. Focal syndrome was the most frequent form of presentation, in the form of cerebral toxoplasmosis. Severely low levels of immunosuppression were found in the study population. Hospital stay is variable and is longer in cases of focal syndrome and meningeal syndrome. We consider it important to continue the present study, which will allow us to increase the sample size.